Erudio Healtherudio.com
Drug
Relatlimab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying relatlimab: SUPRAME. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 6 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| SUPRAME NCT06743126 · Immatics US, Inc. | previously treated, unresectable or metastatic cutaneous melanoma | Phase 3 | 108 | 39 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NICHE NCT03026140 · The Netherlands Cancer Institute DeepView → | early-stage colon cancer | Phase 2 | Deep | View | |||
| RELATIVITY-047 NCT03470922 · Bristol-Myers Squibb DeepView → | previously untreated unresectable or metastatic melanoma | Phase 2/Phase 3 | Deep | View | |||
| RELATIVITY-020 NCT01968109 · Bristol-Myers Squibb StandardView → | advanced solid tumors | Phase 1/Phase 2 | Standard | View | |||
| NEOpredict NCT04205552 · University Hospital, Essen FocusedView → | resectable non-small-cell lung cancer | Phase 2 | Focused | View | |||
| MODERN NCT05987241 · National Cancer Institute (NCI) FocusedView → | muscle-invasive urothelial carcinoma | Phase 2/Phase 3 | Focused | View | |||
| RELATIVITY-1093 NCT06561386 · Bristol-Myers Squibb FocusedView → | Not given | Phase 3 | Focused | View | |||